{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T05:45:24Z","timestamp":1792215924467,"version":"4.4.0"},"reference-count":16,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinical-breast-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.clbc.2026.08.016","type":"journal-article","created":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T07:03:39Z","timestamp":1787727819000},"page":"70-76","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Predictive Effect of the Er\/Ki67 Ratio on Axillary Metastasis in Breast Cancer Patients"],"prefix":"10.1016","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4152-2388","authenticated-orcid":false,"given":"Denizcan","family":"Bozkurt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huseyin","family":"Gobut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.clbc.2026.08.016_bib0001","first-page":"951","article-title":"Sabiston textbook of surgery","volume":"6","author":"Kerja","year":"1967","journal-title":"Angew Chem Int Ed"},{"issue":"3","key":"10.1016\/j.clbc.2026.08.016_bib0002","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"10071","key":"10.1016\/j.clbc.2026.08.016_bib0003","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S0140-6736(16)31392-7","article-title":"The global burden of women\u2019s cancers: a grand challenge in global health","volume":"389","author":"Ginsburg","year":"2017","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.clbc.2026.08.016_bib0004","first-page":"525","article-title":"Correlation between extranodal invasion in axillary lymph node metastasis and prognosis of breast cancer patients","volume":"46","author":"Zhang","year":"2017","journal-title":"Zhonghua Bing Li Xue Za Zhi"},{"issue":"9","key":"10.1016\/j.clbc.2026.08.016_bib0005","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/ans.14382","article-title":"Arm morbidity of axillary dissection with sentinel node biopsy versus delayed axillary dissection","volume":"88","author":"Ballal","year":"2018","journal-title":"ANZ J Surg"},{"issue":"4","key":"10.1016\/j.clbc.2026.08.016_bib0006","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/BF02967614","article-title":"Sentinel node biopsy to avoid axillary lymph node dissection in breast cancer","volume":"9","author":"Motomura","year":"2002","journal-title":"Breast Cancer"},{"issue":"10","key":"10.1016\/j.clbc.2026.08.016_bib0007","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1007\/s00259-009-1145-6","article-title":"Diagnostic value of full-dose FDG PET\/CT for axillary lymph node staging in breast cancer patients","volume":"36","author":"Heusner","year":"2009","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"5","key":"10.1016\/j.clbc.2026.08.016_bib0008","doi-asserted-by":"crossref","DOI":"10.3892\/ol.2020.12136","article-title":"Biomarker heterogeneity between primary breast cancer and synchronous axillary lymph node metastases","volume":"20","author":"Xi","year":"2020","journal-title":"Oncol Lett"},{"issue":"1","key":"10.1016\/j.clbc.2026.08.016_bib0009","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-022-10034-3","article-title":"Prediction model of axillary lymph node status using automated breast ultrasound (ABUS) and Ki-67 status in early-stage breast cancer","volume":"22","author":"Wang","year":"2022","journal-title":"BMC Cancer"},{"issue":"2","key":"10.1016\/j.clbc.2026.08.016_bib0010","doi-asserted-by":"crossref","first-page":"190","DOI":"10.4103\/ijc.IJC_610_18","article-title":"Study of ER, PR, HER2\/neu, p53, and Ki67 expression in primary breast carcinomas and synchronous metastatic axillary lymph nodes","volume":"57","author":"Khande","year":"2020","journal-title":"Indian J Cancer"},{"issue":"15","key":"10.1016\/j.clbc.2026.08.016_bib0011","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1001\/jama.2015.12783","article-title":"Breast cancer screening for women at average risk: 2015 guideline update from the American Cancer Society","volume":"314","author":"Oeffinger","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.clbc.2026.08.016_bib0012","unstructured":"American Cancer Society. Surgery for breast cancer | breast cancer treatment. 2024. Available at: https:\/\/www.cancer.org\/cancer\/types\/breast-cancer\/treatment\/surgery-for-breast-cancer.html."},{"key":"10.1016\/j.clbc.2026.08.016_bib0013","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jss.2021.09.039","article-title":"Sentinel lymph node positive rate predicts non-sentinel lymph node metastasis in breast cancer","volume":"271","author":"Wang","year":"2022","journal-title":"J Surg Res"},{"issue":"29","key":"10.1016\/j.clbc.2026.08.016_bib0014","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000029286","article-title":"Risk factors for nonsentinel lymph node metastasis in 443 breast cancer patients with sentinel lymph node-positive","volume":"101","author":"Cai","year":"2022","journal-title":"Medicine"},{"issue":"10","key":"10.1016\/j.clbc.2026.08.016_bib0015","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1001\/jama.2017.11470","article-title":"Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 (Alliance) randomized clinical trial","volume":"318","author":"Giuliano","year":"2017","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.clbc.2026.08.016_bib0016","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1200\/JCO.22.01565","article-title":"Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer: 10-year results of the randomized controlled EORTC 10981-22023 AMAROS trial","volume":"41","author":"Bartels","year":"2023","journal-title":"J Clin Oncol"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820926001540?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820926001540?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T05:32:10Z","timestamp":1792215130000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820926001540"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":16,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S1526820926001540"],"URL":"https:\/\/doi.org\/10.1016\/j.clbc.2026.08.016","relation":{},"ISSN":["1526-8209"],"issn-type":[{"value":"1526-8209","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predictive Effect of the Er\/Ki67 Ratio on Axillary Metastasis in Breast Cancer Patients","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clbc.2026.08.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}